key: cord-0072290-u479i1y8 authors: Horne, Benjamin D.; Muhlestein, Joseph B.; May, Heidi T.; Le, Viet T.; Bair, Tami L.; Bennett, Sterling T.; Knowlton, Kirk U.; Anderson, Jeffrey L. title: Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial date: 2021-12-09 journal: Nutrients DOI: 10.3390/nu13124407 sha: f791beb1c7e9a0a25b330dc46dbbd2e7d9a2d752 doc_id: 72290 cord_uid: u479i1y8 Red cell distribution width (RDW) predicts cardiovascular outcomes, but it is unstudied with regard to intermittent fasting. In WONDERFUL trial subjects, the effect of the interaction between baseline RDW and intermittent fasting on changes in insulin and other cardiometabolic endpoints and the effect of fasting on changes in RDW were evaluated. The subjects enrolled were aged 21–70 years and were free of statins, anti-diabetes medications, and chronic diseases, and had ≥1 metabolic syndrome feature, as well as elevated low-density lipoprotein cholesterol. Subjects were randomized to 24-h, water-only fasting (twice per week for 4 weeks, once per week for 22 weeks) or 26 weeks of ad libitum eating. Subjects (N = 71; n = 38 intermittent fasting, n = 33 controls) had more substantial changes in insulin in intermittent fasting vs. controls (−3.45 ± 2.27 vs. 0.48 ± 3.55 mIU/L) when baseline RDW size distribution (RDW-SD) was ≥median (42.6 fL) than